This extract (below) from * about a week ago (sorry for the late pick up) - Whilst it is * that wrote this (there is usually a bit of "inflammation" in the stories there), I think they have picked some of the more realistic acquisition targets including BNO. GLTA
"Potential takeovers could include medical devices companies Impedimed (ASX:IPD), AirXpanders (ASX:AXP), Osprey (ASX:OSP) and Visioneering (ASX:VTI), and biotechs Paradigm Biopharma (ASX:BIO) and perhaps Bionomics (ASX:BNO)."
BNO Price at posting:
37.5¢ Sentiment: Buy Disclosure: Held